Cargando…

The Benefit of Zinc Sulfate in Oropharyngeal Mucositis during Hyperfractionated Accelerated Concomitant Boost Radiotherapy with Concurrent Cisplatin for Advanced-Stage Oropharyngeal and Hypopharyngeal Cancers

BACKGROUND: Radiation-induced oropharyngeal mucositis is a major problem causing widespread clinical symptoms and may interfere with treatment plans, ultimately jeopardizing patient outcome. Zinc supplementation may be considered beneficial in preventing acute toxicity during chemoradiation. AIMS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anandhi, P, Sharief, Rahamathulla Mudassar, Rahila, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888420/ https://www.ncbi.nlm.nih.gov/pubmed/33623304 http://dx.doi.org/10.4103/IJPC.IJPC_20_20

Ejemplares similares

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins
por: Amini, Arya, et al.
Publicado: (2019)

Management of Oropharyngeal Dysphagia in Laryngeal and Hypopharyngeal Cancer
por: Granell, Jose, et al.
Publicado: (2012)

Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome
por: Nowak-Sadzikowska, Jadwiga, et al.
Publicado: (2013)

Radiomics features analysis of PET images in oropharyngeal and hypopharyngeal cancer
por: Liao, Ken Ying-Kai, et al.
Publicado: (2019)

Effect of zinc on oropharyngeal mucositis in children with acute leukemia undergoing chemotherapy
por: Gutiérrez-Vargas, Rosaura, et al.
Publicado: (2020)

Routine Endoscopy for Esophageal Cancer Is Suggestive for Patients with Oral, Oropharyngeal and Hypopharyngeal Cancer
por: Hung, Shih-Han, et al.
Publicado: (2013)

Editorial: News and update in transoral robotic surgery in oropharyngeal, hypopharyngeal, and laryngeal cancers
por: Mat Lazim, Norhafiza, et al.
Publicado: (2023)

HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy
por: Zděblová Čermáková, Zuzana, et al.
Publicado: (2023)

Correction: Routine Endoscopy for Esophageal Cancer Is Suggestive for Patients with Oral, Oropharyngeal and Hypopharyngeal Cancer
por: Hung, Shih-Han, et al.
Publicado: (2017)

The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy
por: Elumalai, Thiraviyam, et al.
Publicado: (2021)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
por: HASEGAWA, MASAHIRO, et al.
Publicado: (2014)

Oropharyngeal mucosal transmission of Zika virus in rhesus macaques
por: Newman, Christina M., et al.
Publicado: (2017)

Prophylaxis with oral zinc sulfate against radiation-induced oropharyngeal mucositis in patients with head and neck cancer: Protocol for a meta-analysis of randomized controlled trials
por: Shuai, Ting, et al.
Publicado: (2018)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis
por: Bertolini, M., et al.
Publicado: (2021)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
por: Nanda, R., et al.
Publicado: (2019)

Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients
por: Zaboli, David, et al.
Publicado: (2012)

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients
por: Charles, Kellie A., et al.
Publicado: (2016)

Comparative effectiveness of simultaneous integrated boost vs sequential intensity-modulated radiotherapy for oropharyngeal or hypopharyngeal cancer patients: A population-based propensity score-matched analysis
por: Kuo, Yao-Hung, et al.
Publicado: (2019)

Intra-arterial chemoradiation for T3-4 oral cavity cancer: Treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma
por: Doweck, Ilana, et al.
Publicado: (2008)

Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma
por: Pace, Leonardo, et al.
Publicado: (2021)

Validity and reliability of the Persian version of the oropharyngeal Mucositis quality of life scale
por: Hasheminasab, Fatemeh Sadat, et al.
Publicado: (2021)

Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes
por: Soliman, Ola, et al.
Publicado: (2023)

Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy
por: Ng, Shu-Hang, et al.
Publicado: (2013)

[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy
por: Ishihara, Takeaki, et al.
Publicado: (2017)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
por: Roskies, M., et al.
Publicado: (2016)

Molecular Pathogenesis of Human Immunodeficiency Virus-Associated Disease of Oropharyngeal Mucosal Epithelium
por: Tugizov, Sharof M.
Publicado: (2023)

Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin
por: Kovács, A F, et al.
Publicado: (2002)

Oropharyngeal Crohn’s disease
por: Mohamed, Rachid, et al.
Publicado: (2008)

Oropharyngeal and Tonsillar Infections
por: Naples, James, et al.
Publicado: (2016)

A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
por: Nishimura, Goshi, et al.
Publicado: (2019)

Analysis of Race and Gender Disparities in Mortality Trends from Patients Diagnosed with Nasopharyngeal, Oropharyngeal and Hypopharyngeal Cancer from 2000 to 2017
por: Chiruvella, Varsha, et al.
Publicado: (2021)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Does the Oropharyngeal Fat Tissue Influence the Oropharyngeal Airway in Snorers? Dynamic CT Study
por: Aksoz, Tolga, et al.
Publicado: (2004)

Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit
por: Nangia, Sapna, et al.
Publicado: (2023)

Isolated oropharyngeal abscess with hypopharyngeal extension recurring 12 years after initial surgical management: A case report and review of the literature
por: Khoury, Michel, et al.
Publicado: (2022)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2bunm6tcd3fi6m437j3pbrmdrn